Home
>
National Drug Code (NDC)
>
NABI-HB
NABI-HB - 59730-4202-1 - (HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN)
Drug Information of NABI-HB
| Product NDC: | 59730-4202 |
| Proprietary Name: | NABI-HB |
| Non Proprietary Name: | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| Active Ingredient(s): | 312 [iU]/mL & nbsp; HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NABI-HB
| Product NDC: | 59730-4202 |
| Labeler Name: | Biotest Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA991442 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20100310 |
Package Information of NABI-HB
| Package NDC: | 59730-4202-1 |
| Package Description: | 1 mL in 1 VIAL (59730-4202-1) |
NDC Information of NABI-HB
| NDC Code | 59730-4202-1 |
| Proprietary Name | NABI-HB |
| Package Description | 1 mL in 1 VIAL (59730-4202-1) |
| Product NDC | 59730-4202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20100310 |
| Marketing Category Name | BLA |
| Labeler Name | Biotest Pharmaceuticals Corporation |
| Substance Name | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN |
| Strength Number | 312 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Human Immunoglobulin [EPC],Passively Acquired Immunity [PE],Virus Neutralization [MoA],Virus-specific Hyperimmune Globulins [Chemical/Ingredient],Immunoglobulins [Chemical/Ingredient] |
